Accolade Past Earnings Performance

Past criteria checks 0/6

Accolade's earnings have been declining at an average annual rate of -17.4%, while the Healthcare industry saw earnings growing at 5.7% annually. Revenues have been growing at an average rate of 24.8% per year.

Key information

-17.4%

Earnings growth rate

27.7%

EPS growth rate

Healthcare Industry Growth8.5%
Revenue growth rate24.8%
Return on equity-57.6%
Net Margin-40.4%
Last Earnings Update30 Nov 2024

Recent past performance updates

Recent updates

Accolade: A GARP Stock Trading Well Under 1X Revenues

Dec 05

Accolade: Consider Both Short-Term Revenue Outlook And Rumored Takeover

Sep 09

Slammed 50% Accolade, Inc. (NASDAQ:ACCD) Screens Well Here But There Might Be A Catch

Jun 29
Slammed 50% Accolade, Inc. (NASDAQ:ACCD) Screens Well Here But There Might Be A Catch

Accolade: Mixed Guidance (Rating Downgrade)

Jun 28

Does Accolade (NASDAQ:ACCD) Have A Healthy Balance Sheet?

Jun 05
Does Accolade (NASDAQ:ACCD) Have A Healthy Balance Sheet?

Accolade: Staying Bullish On Favorable Developments

Apr 05

Why We're Not Concerned About Accolade, Inc.'s (NASDAQ:ACCD) Share Price

Feb 17
Why We're Not Concerned About Accolade, Inc.'s (NASDAQ:ACCD) Share Price

Accolade: Remain Confident That FY25 Guided Growth Is Achievable

Jan 17

Accolade: Turning Bullish After Beat-And-Raise Quarter (Rating Upgrade)

Jan 11

Why Investors Shouldn't Be Surprised By Accolade, Inc.'s (NASDAQ:ACCD) 27% Share Price Surge

Jun 13
Why Investors Shouldn't Be Surprised By Accolade, Inc.'s (NASDAQ:ACCD) 27% Share Price Surge

Is There Now An Opportunity In Accolade, Inc. (NASDAQ:ACCD)?

May 02
Is There Now An Opportunity In Accolade, Inc. (NASDAQ:ACCD)?

An Intrinsic Calculation For Accolade, Inc. (NASDAQ:ACCD) Suggests It's 28% Undervalued

Feb 05
An Intrinsic Calculation For Accolade, Inc. (NASDAQ:ACCD) Suggests It's 28% Undervalued

Accolade: Inching Closer To Profitability

Oct 17

Accolade Q2 2023 Earnings Preview

Oct 05

Accolade: Fair And Reasonably Priced, But Needs More Time

Aug 09

Accolade Q1 2023 Earnings Preview

Jun 29

Accolade: Little Recent Applause

Mar 28

Accolade Impresses With Revenue Growth But Faces Operating Losses

Dec 16

Accolade: I May Add To My Position

Oct 18

Accolade, Inc. (NASDAQ:ACCD) Just Reported And Analysts Have Been Lifting Their Price Targets

Jul 11
Accolade, Inc. (NASDAQ:ACCD) Just Reported And Analysts Have Been Lifting Their Price Targets

Revenue & Expenses Breakdown

How Accolade makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

NasdaqGS:ACCD Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Nov 24447-18016692
31 Aug 24441-8016696
31 May 24432-8916599
29 Feb 24414-10016299
30 Nov 23388-12316398
31 Aug 23380-14216799
31 May 23371-15517098
28 Feb 23363-46017599
30 Nov 22358-46418898
31 Aug 22350-40118997
31 May 22336-41719095
28 Feb 22310-12318684
30 Nov 21275-9313875
31 Aug 21230-13211065
31 May 21194-857855
28 Feb 21170-516350
30 Nov 20156-485745
31 Aug 20147-505743
31 May 20140-495642
29 Feb 20133-515642
30 Nov 19123-565543
28 Feb 1995-564336
28 Feb 1877-614331

Quality Earnings: ACCD is currently unprofitable.

Growing Profit Margin: ACCD is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: ACCD is unprofitable, and losses have increased over the past 5 years at a rate of 17.4% per year.

Accelerating Growth: Unable to compare ACCD's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: ACCD is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (10.2%).


Return on Equity

High ROE: ACCD has a negative Return on Equity (-57.6%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/02 02:34
End of Day Share Price 2025/01/31 00:00
Earnings2024/11/30
Annual Earnings2024/02/29

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Accolade, Inc. is covered by 24 analysts. 14 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Matthew GillmorBaird
Zhilin LongBerenberg
Allen LutzBofA Global Research